Literature DB >> 11418128

cis-Inhibition of proteasomal degradation by viral repeats: impact of length and amino acid composition.

A Sharipo1, M Imreh, A Leonchiks, C Brändén, M G Masucci.   

Abstract

The Gly-Ala repeat (GAr) of the Epstein-Barr virus nuclear antigen 1 is a cis acting inhibitor of ubiquitin-proteasome proteolysis. We have investigated the capacity of various repeats to inhibit the turnover of the proteasomal substrate IkappaBalpha. Inhibition of TNFalpha-induced degradation was achieved by insertion of octamers containing three alanines or valines, interspersed by no more then three consecutive glycines. The inhibitory activity was abolished by increasing the length of the spacer, by eliminating the spacers, or by substitution of a single hydrophobic residue with a polar or charged residue. A serine containing octamer was inactive but inhibition was partially restored by insertion of three consecutive repeats. These findings suggest a model where inhibition requires the interaction of at least three alanine residues of the GAr in a beta-strand conformation with adjacent hydrophobic binding pockets of a putative receptor.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11418128     DOI: 10.1016/s0014-5793(01)02542-x

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  7 in total

Review 1.  Peptide-guided gene delivery.

Authors:  Molly E Martin; Kevin G Rice
Journal:  AAPS J       Date:  2007-02-09       Impact factor: 4.009

2.  Slippery substrates impair ATP-dependent protease function by slowing unfolding.

Authors:  Daniel A Kraut
Journal:  J Biol Chem       Date:  2013-10-22       Impact factor: 5.157

3.  Slippery substrates impair function of a bacterial protease ATPase by unbalancing translocation versus exit.

Authors:  Priscilla Hiu-Mei Too; Jenny Erales; Joana Danica Simen; Antonija Marjanovic; Philip Coffino
Journal:  J Biol Chem       Date:  2013-03-25       Impact factor: 5.157

4.  Effects of APC De-targeting and GAr modification on the duration of luciferase expression from plasmid DNA delivered to skeletal muscle.

Authors:  Maria C Subang; Rewas Fatah; Ying Wu; Drew Hannaman; Jason Rice; Claire F Evans; Yuti Chernajovsky; David Gould
Journal:  Curr Gene Ther       Date:  2015       Impact factor: 4.391

5.  Interactions between a subset of substrate side chains and AAA+ motor pore loops determine grip during protein unfolding.

Authors:  Tristan A Bell; Tania A Baker; Robert T Sauer
Journal:  Elife       Date:  2019-06-28       Impact factor: 8.140

Review 6.  Engineered biological entities for drug delivery and gene therapy protein nanoparticles.

Authors:  Joan Domingo-Espín; Ugutz Unzueta; Paolo Saccardo; Escarlata Rodríguez-Carmona; José Luís Corchero; Esther Vázquez; Neus Ferrer-Miralles
Journal:  Prog Mol Biol Transl Sci       Date:  2011       Impact factor: 3.622

7.  Interaction of gamma-herpesvirus genome maintenance proteins with cellular chromatin.

Authors:  Nouman Mughal; Giuseppe Coppotelli; Simone Callegari; Stefano Gastaldello; Maria G Masucci
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.